檢索結果 - Ross, David M

Need to minimize bias when surveying patient attitudes to stopping cml treatment 由 Villemagne–Sanchez, Lucia A., Ross, David M., Schofield, Penelope

獲取全文 獲取全文 獲取全文

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications 由 Ross, David M., Babon, Jeffrey J., Tvorogov, Denis, Thomas, Daniel

獲取全文 獲取全文 獲取全文

Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review 由 Chua, Su J, Morton, Mark R, Svigos, John, Ross, David M, Kane, Simon

獲取全文 獲取全文 獲取全文

Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features 由 Ross, David M., Bartley, Paul A., Goyne, Jarrad, Morley, Alexander A., Seymour, John F., Grigg, Andrew P.

獲取全文 獲取全文 獲取全文

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study 由 Ho, P. Joy, Hiwase, Devendra, Ramakrishna, Raj, Viiala, Nicholas, Solterbeck, Ann, Traficante, Robert, Zor, Evren, Gervasio, Othon L., High, Laura M., Ross, David M., Bowden, Donald K.

獲取全文 獲取全文 獲取全文

Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study 由 Martin, Hilary Laura, Ullah, Shahid, Abbas, Nazim, Scott‐Hoy, Alex, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Roy, Amitesh, Sukumaran, Shawgi, Ross, David M, Khattak, Muhammad Adnan, Koczwara, Bogda

獲取全文 獲取全文 獲取全文

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia 由 Pagani, Ilaria S., Dang, Phuong, Kommers, Ivar O., Goyne, Jarrad M., Nicola, Mario, Saunders, Verity A., Braley, Jodi, White, Deborah L., Yeung, David T., Branford, Susan, Hughes, Timothy P., Ross, David M.

獲取全文 獲取全文 獲取全文

Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody 由 Tvorogov, Denis, Thompson‐Peach, Chloe A L, Foßelteder, Johannes, Dottore, Mara, Stomski, Frank, Onnesha, Suraiya A, Lim, Kelly, Moretti, Paul A B, Pitson, Stuart M, Ross, David M, Reinisch, Andreas, Thomas, Daniel, Lopez, Angel F

獲取全文 獲取全文 獲取全文

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 由 Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin

獲取全文 獲取全文 獲取全文

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 由 Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin

獲取全文 獲取全文 獲取全文

Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis 由 Tvorogov, Denis, Thomas, Daniel, Liau, Nicholas P. D., Dottore, Mara, Barry, Emma F., Lathi, Maya, Kan, Winnie L., Hercus, Timothy R., Stomski, Frank, Hughes, Timothy P., Tergaonkar, Vinay, Parker, Michael W., Ross, David M., Majeti, Ravindra, Babon, Jeffrey J., Lopez, Angel F.

獲取全文 獲取全文 獲取全文

The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study 由 Mascarenhas, John, Passamonti, Francesco, Burbury, Kate, El-Galaly, Tarec Christoffer, Gerds, Aaron, Gupta, Vikas, Higgins, Brian, Wonde, Kathrin, Jamois, Candice, Kovic, Bruno, Huw, Ling-Yuh, Katakam, Sudhakar, Maffioli, Margherita, Mesa, Ruben, Palmer, Jeanne, Bellini, Marta, Ross, David M., Vannucchi, Alessandro M., Yacoub, Abdulraheem

獲取全文 獲取全文 獲取全文

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome 由 Singhal, Deepak, Kutyna, Monika M., Chhetri, Rakchha, Wee, Li Yan A., Hague, Sophia, Nath, Lakshmi, Nath, Shriram V., Sinha, Romi, Wickham, Nicholas, Lewis, Ian D., Ross, David M., Bardy, Peter G., To, Luen Bik, Reynolds, John, Wood, Erica M., Roxby, David J., Hiwase, Devendra K.

獲取全文 獲取全文 獲取全文

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial 由 Radich, Jerald P., Hochhaus, Andreas, Masszi, Tamás, Hellmann, Andrzej, Stentoft, Jesper, Casares, María Teresa Gómez, García-Gutiérrez, J. Valentín, Conneally, Eibhlin, le Coutre, Philipp D., Gattermann, Norbert, Martino, Bruno, Saussele, Susanne, Giles, Francis J., Ross, David M., Aimone, Paola, Li, Sai, Titorenko, Ksenia, Saglio, Giuseppe

獲取全文 獲取全文 獲取全文

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib 由 Cheah, Chan Y., Burbury, Kate, Apperley, Jane F., Huguet, Francoise, Pitini, Vincenzo, Gardembas, Martine, Ross, David M., Forrest, Donna, Genet, Philippe, Rousselot, Philippe, Patton, Nigel, Smith, Graeme, Dunbar, Cynthia E., Ito, Sawa, Aguiar, Ricardo C. T., Odenike, Olatoyosi, Gimelfarb, Alla, Cross, Nicholas C. P., Seymour, John F.

獲取全文 獲取全文 獲取全文

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study 由 Ross, David M., Masszi, Tamas, Gómez Casares, María Teresa, Hellmann, Andrzej, Stentoft, Jesper, Conneally, Eibhlin, Garcia-Gutierrez, Valentin, Gattermann, Norbert, le Coutre, Philipp D., Martino, Bruno, Saussele, Susanne, Giles, Francis J., Radich, Jerald P., Saglio, Giuseppe, Deng, Weiping, Krunic, Nancy, Bédoucha, Véronique, Gopalakrishna, Prashanth, Hochhaus, Andreas

獲取全文 獲取全文 獲取全文

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets 由 Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.

獲取全文 獲取全文 獲取全文

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia 由 Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

獲取全文 獲取全文 獲取全文

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia 由 Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

獲取全文 獲取全文 獲取全文

COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement 由 McCaughan, Georgia, Di Ciaccio, Pietro, Ananda‐Rajah, Michelle, Gilroy, Nicole, MacIntyre, Raina, Teh, Benjamin, Weinkove, Robert, Curnow, Jennifer, Szer, Jeff, Enjeti, Anoop K, Ross, David M, Mulligan, Stephen, Trotman, Judith, Dickinson, Michael, Quach, Hang, Choi, Phillip, Polizzotto, Mark N., Tam, Constantine S., Ho, P. Joy, Ku, Matthew, Gregory, Gareth, Gangatharan, Shane, Hapgood, Greg, Cochrane, Tara, Cheah, Chan, Gibbs, Simon, Wei, Andrew, Johnston, Anna, Greenwood, Matthew, Prince, H. Miles, Latimer, Maya, Berkahn, Leanne, Wight, Joel, Armytage, Tasman, Hamad, Nada

獲取全文 獲取全文 獲取全文